The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Systemic Immune Activation Leads to Neuroinflammation and Sickness Behavior in Mice
Open accessAbstract
Substantial evidence indicates an association between clinical depression and altered immune function. Systemic administration of bacterial lipopolysaccharide (LPS) is commonly used to study inflammation-associated behavioral changes in rodents. In these experiments, we tested the hypothesis that peripheral immune activation leads to neuroinflammation and depressive-like behavior in mice. We report that systemic administration of LPS induced astrocyte activation in transgenic GFAP-luc mice and increased immunoreactivity against the microglial marker ionized calcium-binding adapter molecule 1 in the dentate gyrus of wild-type mice. Furthermore, LPS treatment caused a strong but transient increase in cytokine levels in the serum and brain. In addition to studying LPS-induced neuroinflammation, we tested whether sickness could be separated from depressive-like behavior by evaluating LPS-treated mice in a panel of behavioral paradigms. Our behavioral data indicate that systemic LPS administration caused sickness and mild depressive-like behavior. However, due to the overlapping time course and mild effects on depression-related behavior per se, it was not possible to separate sickness from depressive-like behavior in the present rodent model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“…been reported that depressed patients commonly display alterations in their immune system, including impaired cellular immunity and increased levels of proinflammatory cytokines; for reviews, see Schiepers et al. 2005 [4], Dowlati et al. 2010 [5], Blume et al. 2011 [6], and Howren et al. 2009 [7].”
BackgroundThe Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 1×
“Hindawi Publishing Corporation Mediators of Inflammation Volume 2013, Article ID 271359, 14 pages http://dx.doi.org/10.1155/2013/271359”
BackgroundInfluentialCytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223 · cited 1×
“rewarding activities), sleep disturbances, and increased sensitivity to pain [18, 19].”
BackgroundSystemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“response to systemic LPS administration and are in line with previous reports of increased IBA1 immunoreactivity in the hippocampus of LPS-treated mice [44, 52].”
ResultReactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Cited by
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172
“Some in vivo studies show astrocyte proliferation and activation, followed by astrocyte loss (Biesmans et al., 2013; Cardoso et al., 2015), and another study demonstrates structural changes in astrocytic end-feet (Fan et al., 2014), which could lead to disruptive change.”
The blood-brain barrier in aging and neurodegeneration
Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738
Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms
Huang, X., Hussain, B., & Chang, J. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13569 · Cited by 709
Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
“Based on our current results, we speculate that the intestinal inflammation induced by bacterial elements through the LPS-activated TLR4/MyD88/NF-κB signaling pathway together with the following sustained and relatively severe disruption of the intestinal barrier that can leak pro-inflammatory factors into the circula…”
BackgroundThe gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
Leclercq, S., Mian, F. M., Stanisz, A. M., Bindels, L. B., Cambier, E., Ben-Amram, H., Koren, O., Forsythe, P., & Bienenstock, J. (2017) · Nature Communications · doi:10.1038/ncomms15062 · Cited by 434
NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings
Kaufmann, F. N., Costa, A. P., Ghisleni, G., Diaz, A. P., Rodrigues, A. L. S., Peluffo, H., & Kaster, M. P. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.03.002 · Cited by 370
“…(Hinwood et al., 2013; Liu et al., 2015; Pan et al., 2014), prenatal stress in rats (Slusarczyk et al., 2015), restraint stress (Tynan et al., 2010), social defeat (Wohleb et al., 2011), and lipopolysaccharide (LPS)-induced depressive-like behavior (Biesmans et al., 2013; van Buel et al., 2015).”
Inflammasomes in neuroinflammation and changes in brain function: a focused review
Singhal, G., Jaehne, E. J., Corrigan, F., Toben, C., & Baune, B. T. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00315 · Cited by 365
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET
Sandiego, C. M., Gallezot, J.-D., Pittman, B., Nabulsi, N., Lim, K., Lin, S.-F., Matuskey, D., Lee, J.-Y., O’Connor, K. C., Huang, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511003112 · Cited by 356
Nava Catorce, M., & Gevorkian, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151204122017 · Cited by 356
The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324
Neuroprotective Effect of Quercetin Against the Detrimental Effects of LPS in the Adult Mouse Brain
Khan, A., Ali, T., Rehman, S. U., Khan, M. S., Alam, S. I., Ikram, M., Muhammad, T., Saeed, K., Badshah, H., & Kim, M. O. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01383 · Cited by 261
Savignac, H. M., Couch, Y., Stratford, M., Bannerman, D. M., Tzortzis, G., Anthony, D. C., & Burnet, P. W. J. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.10.007 · Cited by 223
“Notably, rodents administered with a single, peripheral dose of lipopolysaccharides (LPS) from Gram-negative bacteria, display ‘sickness behaviour’ where a reduction of locomotor activity within the first few hours is a principal feature (Cunningham et al., 2009; Biesmans et al., 2013).”
Antidepressant therapies inhibit inflammation and microglial M1-polarization
Kalkman, H. O., & Feuerbach, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.001 · Cited by 212
Inflammatory cytokine-associated depression
Lotrich, F. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.06.032 · Cited by 183
Lasselin, J., Schedlowski, M., Karshikoff, B., Engler, H., Lekander, M., & Konsman, J. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.001 · Cited by 165
“Employing animal tests, such as the Porsolt forced swim test (FST) or the tail suspension test (TLT), to assess so-called helplessness or behavioral despair as features of depression is complicated by the fact that administration of LPS or IL-1β leads to a general reduction in locomotor activity (Biesmans et al., 2013…”
Neuropathobiology of COVID-19: The Role for Glia
Tremblay, M.-E., Madore, C., Bordeleau, M., Tian, L., & Verkhratsky, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592214 · Cited by 159
Zhao, Z., Li, F., Ning, J., Peng, R., Shang, J., Liu, H., Shang, M., Bao, X.-Q., & Zhang, D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.020 · Cited by 137
Jangra, A., Lukhi, M. M., Sulakhiya, K., Baruah, C. C., & Lahkar, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.031 · Cited by 122
Ge, L., Liu, L., Liu, H., Liu, S., Xue, H., Wang, X., Yuan, L., Wang, Z., & Liu, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.026 · Cited by 106
Farzi, A., Reichmann, F., Meinitzer, A., Mayerhofer, R., Jain, P., Hassan, A. M., Fröhlich, E. E., Wagner, K., Painsipp, E., Rinner, B., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.011 · Cited by 68
“Our observation is backed by other studies in which the duration of LPS-induced sickness has been found to overlap with that of depression-related behavior (Biesmans et al., 2013).”
Shi, Z., Ren, H., Huang, Z., Peng, Y., He, B., Yao, X., Yuan, T.-F., & Su, H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0212-9 · Cited by 62
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge
Murtaj, V., Belloli, S., Di Grigoli, G., Pannese, M., Ballarini, E., Rodriguez-Menendez, V., Marmiroli, P., Cappelli, A., Masiello, V., Monterisi, C., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00299 · Cited by 58
Enduring Changes in Neuronal Function upon Systemic Inflammation Are NLRP3 Inflammasome Dependent
Beyer, M. M. S., Lonnemann, N., Remus, A., Latz, E., Heneka, M. T., & Korte, M. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0200-20.2020 · Cited by 55
“Furthermore, it was shown that although the peripheral cytokines or the LPS itself do not diffuse across the blood brain barrier (Wendeln et al., 2018), the systemic inflammation leads to neuroinflammation mediated by glia cells (Qin et al., 2007; Biesmans et al., 2013).”
BackgroundHe, M.-C., Shi, Z., Sha, N.-N., Chen, N., Peng, S.-Y., Liao, D.-F., Wong, M.-S., Dong, X.-L., Wang, Y.-J., Yuan, T.-F., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.021 · Cited by 54
Whylings, J., Rigney, N., Peters, N. V., de Vries, G. J., & Petrulis, A. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.015 · Cited by 37
“While the LPS dose used is highly variable across previous studies, inflammation and sickness behavior after LPS administration have generally been reported to occur from 2 hours to over 24 hours post-injection (Biesmans et al., 2013; Dantzer et al., 2008), and the dose of LPS used in this study reliably induces sickn…”
MethodEffect of 2 Psychotherapies on Depression and Disease Activity in Pediatric Crohnʼs Disease
Szigethy, E., Youk, A. O., Gonzalez-Heydrich, J., Bujoreanu, S. I., Weisz, J., Fairclough, D., Ducharme, P., Jones, N., Lotrich, F., Keljo, D., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000358 · Cited by 34
Vicente-Rodríguez, M., Singh, N., Turkheimer, F., Peris-Yague, A., Randall, K., Veronese, M., Simmons, C., Karim Haji-Dheere, A., Bordoloi, J., Sander, K., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.05.025 · Cited by 28
Bristot, G., Ascoli, B. M., Scotton, E., Géa, L. P., Pfaffenseller, B., & Kauer-Sant’Anna, M. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-0001 · Cited by 18
Metadata
- Authors
- Biesmans, S., Meert, T. F., Bouwknecht, J. A., Acton, P. D., Davoodi, N., De Haes, P., Kuijlaars, J., Langlois, X., Matthews, L. J. R., Ver Donck, L., Hellings, N., & Nuydens, R.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-14
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- OpenAlex
- W1988940166
- Cited by
- 382
- References
- 68
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.